Skip to content

Reperfusion With Cooling in Cerebral Acute Ischemia

Phase 1 Study of Mild Induced Hypothermia After Endovascular Revascularization in Acute Ischemic Stroke of the Anterior Circulation

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01585597
Acronym
ReCCLAIM
Enrollment
20
Registered
2012-04-26
Start date
2012-05-31
Completion date
2012-08-31
Last updated
2014-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Keywords

Ischemic Stoke, Endovascular Reperfusion, Reperfusion Injury, Mild hypothermia

Brief summary

The purpose of this study is to determine whether reducing a patients body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients that have suffered a significant interruption of blood flow to an area of brain (occlusion of large proximal cerebral artery) and have undergone successful removal of that interruption (revascularization).

Interventions

DEVICEZoll- Coolgaurd 3000

Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-85 years old * Symptoms consistent with an ischemic stroke with a large vessel occlusion (MCA, ICA-terminus) as determined by vascular imaging * ASPECTS score of 5-7 on non-contrast CT of the brain * Ability to undergo endovascular reperfusion therapy * Must have no contraindications to general anesthesia * A pre-treatment modified Rankin Score of 0 or 1 * Arterial puncture performed under 8 hours from symptom onset or last seen normal * Immediate post reperfusion CT scan shows no hemorrhage

Exclusion criteria

* Bleeding diathesis with a platelet count \< 50,000 or INR \> 1.5 * Involved in another clinical trial * History of dementia * End stage renal disease on hemodialysis * History of ventricular dysrhythmias * Life threatening medical condition precluding survival under 6 months * Presence of an IVC filter * Contrast dye allergy with history of anaphylaxis

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Reperfusion Injury \ Hemorrhagic Transformation24 HoursAsymptomatic and symptomatic Hemorrhages defined as homogenous density occupying \>30% of the infarct zone with mass effect

Secondary

MeasureTime frameDescription
Modified Rankin Scale 0-290 days post hospitalizationModified Rankin Score 0=no symptoms 1. no significant disability 2. slight disability needs help 3. moderate disability 4. moderate serve disability 5. severe disability 0-2 = good outcome 3-5= poor outcome

Countries

United States

Participant flow

Participants by arm

ArmCount
Mild Hypothermia
Reduction of body temperature to 34 degrees centigrade. Zoll- Coolgaurd 3000: Goal temperature of 33 degrees Centigrade for a duration of 12 hours and then actively rewarmed by 0.2 degrees Centigrade per hour.
20
Total20

Baseline characteristics

CharacteristicMild Hypothermia
Age, Continuous59 years
STANDARD_DEVIATION 14
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
8 / 20

Outcome results

Primary

Number of Participants With Reperfusion Injury \ Hemorrhagic Transformation

Asymptomatic and symptomatic Hemorrhages defined as homogenous density occupying \>30% of the infarct zone with mass effect

Time frame: 24 Hours

ArmMeasureValue (NUMBER)
Mild HypothermiaNumber of Participants With Reperfusion Injury \ Hemorrhagic Transformation3 participants
Secondary

Modified Rankin Scale 0-2

Modified Rankin Score 0=no symptoms 1. no significant disability 2. slight disability needs help 3. moderate disability 4. moderate serve disability 5. severe disability 0-2 = good outcome 3-5= poor outcome

Time frame: 90 days post hospitalization

ArmMeasureValue (NUMBER)
Mild HypothermiaModified Rankin Scale 0-220 participants Modified Rankin Scal 0-2

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026